Health IT Certification Moves Forward


By Neil Versel, contributing editor

November 11, 2008 | WASHINGTON—The American Medical Informatics Association (AMIA) is turning its attention to medical specialty boards in its bid for recognition of clinical informatics as a distinct medical subspecialty, following the approval of detailed plans for physician informatician training and competency.

AMIA board members signed off on two documents, “Core Content for the Subspecialty of Clinical Informatics” and “Training Requirements for the Subspecialty of Clinical Informatics,” late Saturday. Some of the authors discussed the requirements and their strategy here Monday at the organization’s annual meeting.

“I think this is a landscape-changing event for the field of informatics,” says past AMIA board chairman Charles Safran, clinical informatics chief at Beth Israel Deaconess Medical Center in Boston. If AMIA is successful, U.S. physicians would be able to earn true board certification in clinical informatics, on equal footing as radiation oncology, pediatric cardiology, critical care medicine, or any other subspecialty.

“This could be the first subspecialty in medicine that cuts across all 24 [specialty] boards,” says Benson Munger, associate director of the Arizona Emergency Medicine Research Center (Tucson).

But first, AMIA must sell its plan to the American Board of Medical Specialties (ABMS), the Accreditation Council for Graduate Medical Education (ACGME), and individual medical specialty boards.

A timeline shown Monday assumes AMIA will find a sponsoring specialty board early in 2009 and apply for ABMS subcertification by next summer, in time for the ABMS to go through the first of two required readings in September. On this schedule, the earliest ABMS could approve the application is March 2010. Following ABMS subcertification, AMIA would then bring its proposed training program to ACGME no earlier than the second half of 2010 for possible approval in early 2011.

The best-case scenario, according to Munger, would be for subcertification training to begin at accredited medical schools and residency and internship programs by the fall of 2011.

Meanwhile, once ABMS has the application, AMIA would begin developing the subcertification exam for physicians who have completed their medical training. The test could be offered as soon as the board of medical specialties approves the subspecialty.

The AMIA documents, developed with a $300,000 grant from the Robert Wood Johnson Foundation, (see “AMIA to Develop Clinical Informatics as Certifiable Specialty”), says clinical informatics is at the nexus of clinical care, the business processes of health care, and information technology. Clinical informaticians—AMIA’s preferred term—must master a wide range of disciplines, including medical knowledge; informatics; the health care “environment” of delivery systems and data flow; how health-IT affects clinical decision-making, users, and patients; process re-engineering; systems implementation; clinician adoption of IT; and organizational leadership, according to the core content.

“We need to lead and manage change. We need to be there in the clinical environment,” AMIA president and chief executive Don Detmer says.

On the training side, AMIA proposes a two-year fellowship program that must be completed within a four-year span, and any accredited clinical informatics program should have full institutional support. There also is a rotation requirement, to account for at least 15 percent of the training period. Rotations might include shadowing a nursing team, working in a records room, or helping in an IT department.

“I think we’ll need clinical sites to provide the training. We can’t do it in the back room,” says Reed Gardner, retired medical informatics chairman at the University of Utah, who chaired the team that developed the core content.

As with new subspecialties, Munger says there would be a clinical informatics practice track during the first five to seven years after approval for those physicians who did not have access to an accredited training program.

 

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Life Science Webcasts & Podcasts

medidata podcast #8 Meeting Today’s Challenges in Clinical Trial Supply Management
Sponsored by: Medidata Solutions Worldwide  

Setting up and managing the clinical trial involves many complex procedures. Among the most challenging are planning and executing the logistics of the trial’s clinical supplies. This podcast focuses in depth on the following topics which trace current practices and future evolution of this crucial aspect of clinical trials:

  • Current practices in clinical trial logistics
  • Comparing advances in clinical supply practices to  other aspects of clinical trials 
  • Where current practices fall short of meeting the challenges
  • Trends and evolving improvements that may change the way logistics are conducted

Listen Now  


More Podcasts

Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .